CJC-1295 + Ipamorelin
A GHRH analog paired with a ghrelin-receptor agonist — the two halves of the GH pulse, and the most-studied combination in this category. Pre-blended at 10 mg, or as separate vials.
- CJC-1295 (No DAC)10mg
- Ipamorelin5mg
GH secretagogues, GHRH analogs and a long-acting IGF-1 — the signal, not the hormone.
Everything on this shelf is studied for what it asks the pituitary or the IGF axis to do, not growth hormone itself. The GHRH analogs come in two clearances — CJC-1295 without DAC and with — alongside sermorelin, the selective secretagogue ipamorelin, the pre-mixed CJC-1295 + ipamorelin blend, and IGF-1 LR3.

Lab testedGHRH analog, no DAC — clears fast for pulsatile-release models.

GHRH analog with DAC — extended half-life for sustained-release models. 2 mg.

GHRH analog + selective secretagogue, pre-mixed at 10 mg.
Lab testedSelective ghrelin-receptor agonist — the mild secretagogue. 5 mg.

GHRH (1-29) — the shortest fragment that still binds the receptor.
Lab testedLong-acting IGF-1 analog with reduced binding-protein affinity. 1 mg.
Which compounds appear together in the published work on this shelf, and which of those we supply pre-blended at a printed ratio. Descriptions of the literature, not instructions — every product is supplied for laboratory research use only.
A GHRH analog paired with a ghrelin-receptor agonist — the two halves of the GH pulse, and the most-studied combination in this category. Pre-blended at 10 mg, or as separate vials.
The same GHRH-plus-secretagogue logic with the shorter GHRH (1-29) analog, which clears faster than CJC-1295 in pulsatile-release models.
Not a pairing — a choice, and the whole reason this category has two CJC-1295 listings. The DAC modification extends half-life for sustained-release models; the no-DAC variant clears fast for pulsatile work. Both stocked, both labelled.
Selank, Semax and DSIP — as lyophilised vials and pre-mixed nasal sprays.

GLP-class agonists and metabolic-signalling compounds — from semaglutide to the tri-agonist.

BPC-157, TB-500, KPV, glutathione — and the BPC-157 + TB-500 blend at a printed ratio.

GH secretagogues, GHRH analogs and a long-acting IGF-1 — the signal, not the hormone.

NAD+, epithalon and the mitochondrial peptides MOTS-c and SS-31.

GHK-Cu, the Glow and Klow blends, and the melanocortin agonists MT-2 and PT-141.

Everything on this page is supplied strictly for laboratory research. These compounds are not drugs, foods, cosmetics or medical devices, are not for human or veterinary consumption or administration, and are not intended to diagnose, treat, cure or prevent any disease. Purchasing requires confirmation that you are 21 or older and a qualified researcher.
Statements here describe the compounds and the published literature concerning them — not outcomes in any person — and nothing on this page is medical advice. Purity figures are determined by HPLC with mass-spectrometric confirmation and apply to the lot identified on its certificate.
Restocks & new lots
A new lot, a new certificate, a new format. Nothing else, ever.